Patient Satisfaction and Reported Outcomes on the Management of Actinic Keratosis

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2017 May 30

PMID 28553130

Citations 8

Authors

Raveena Khanna

Anshika Bakshi

Yasmin Amir

Gary Goldenberg

Affiliations

Soon will be listed here.

Abstract

Actinic keratosis (AK) is a common dermatologic condition in which hyperplastic epidermal lesions develop in response to excessive and chronic exposure to ultraviolet (UV) radiation. If left untreated, AK can progress to squamous cell carcinomas of the skin. Incidence is rising worldwide as a result of the progressive aging of populations and an increase in lifetime cumulative exposure to UV radiation. Currently, various treatment options exist, which range from topical medications to light-based therapies and procedural modalities. In this article, we will review the treatment options for AK with a focus on assessments of patient satisfaction with treatment.

Citing Articles

Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm of the face or scalp in patients with actinic keratosis: A phase 3 study.

Bhatia N, Lain E, Jarell A, DuBois J, Tamarit M, Falques M JAAD Int. 2024; 17:6-14.

PMID: 39268198 PMC: 11387381. DOI: 10.1016/j.jdin.2024.07.001.

Developing a questionnaire for assessing clinician- and patient-reported outcomes in actinic keratosis: Results from an expert panel.

Berman B, Armstrong A, Lebwohl M, Grada A, Bhatia N, Patel V JAAD Int. 2024; 16:192-198.

PMID: 39040844 PMC: 11262182. DOI: 10.1016/j.jdin.2023.09.006.

The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion.

Szeimies R, Ulrich C, Ferrandiz-Pulido C, Hofbauer G, Lear J, Lebbe C Dermatol Ther (Heidelb). 2024; 14(7):1739-1753.

PMID: 38902589 PMC: 11264500. DOI: 10.1007/s13555-024-01215-y.

Anti-tumor effects of tirbanibulin in squamous cell carcinoma cells are mediated via disruption of tubulin-polymerization.

DeTemple V, Walter A, Bredemeier S, Gutzmer R, Schaper-Gerhardt K Arch Dermatol Res. 2024; 316(7):341.

PMID: 38847867 PMC: 11161541. DOI: 10.1007/s00403-024-03032-x.

Treatment Satisfaction and Acceptability of 20% Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses of the Face, Scalp, and Upper Extremities.

Piacquadio D, Berman B, Siegel D, Bhatia N, Brocato J, Squittieri N J Clin Aesthet Dermatol. 2023; 16(12):46-51.

PMID: 38125671 PMC: 10729804.

References

Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R . Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol. 2003; 139(10):1325-32. DOI: 10.1001/archderm.139.10.1325. View

Ackerman A, Mones J . Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol. 2006; 155(1):9-22. DOI: 10.1111/j.1365-2133.2005.07121.x. View

Szpringer E, Lutnicki K, Marciniak A . Photodynamic therapy--mechanism and employment. Ann Univ Mariae Curie Sklodowska Med. 2005; 59(2):498-502. View

Tutrone W, Saini R, Caglar S, Weinberg J, Crespo J . Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids. Cutis. 2003; 71(5):373-9. View

Shergill B, Zokaie S, Carr A . Non-adherence to topical treatments for actinic keratosis. Patient Prefer Adherence. 2014; 8:35-41. PMC: 3872140. DOI: 10.2147/PPA.S47126. View

Augustin M, Tu J, Knudsen K, Erntoft S, Larsson T, William Hanke C . Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes. J Am Acad Dermatol. 2015; 72(5):816-21. DOI: 10.1016/j.jaad.2015.01.036. View

Alchin D . Ingenol mebutate: a succinct review of a succinct therapy. Dermatol Ther (Heidelb). 2014; 4(2):157-64. PMC: 4257954. DOI: 10.1007/s13555-014-0061-2. View

Waalboer-Spuij R, Holterhues C, van Hattem S, Schuttelaar M, Gaastra M, Kuijpers D . Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients. Dermatology. 2015; 231(1):56-62. DOI: 10.1159/000381420. View

Del Rosso J . New and emerging topical approaches for actinic keratoses. Cutis. 2003; 72(4):273-6, 279. View

10.

Tierney E, Eide M, Jacobsen G, Ozog D . Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther. 2008; 10(2):81-6. DOI: 10.1080/14764170802056117. View

11.

Stockfleth E, Peris K, Guillen C, Cerio R, Basset-Seguin N, Foley P . Physician perceptions and experience of current treatment in actinic keratosis. J Eur Acad Dermatol Venereol. 2014; 29(2):298-306. DOI: 10.1111/jdv.12530. View

12.

Agostinis P, Berg K, Cengel K, Foster T, Girotti A, Gollnick S . Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011; 61(4):250-81. PMC: 3209659. DOI: 10.3322/caac.20114. View

13.

Emilio J, Schwartz M, Feldman E, Bieber A, Bienenfeld A, Jung M . Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study. Clin Cosmet Investig Dermatol. 2016; 9:89-93. PMC: 4845892. DOI: 10.2147/CCID.S100999. View

14.

Segatto M, Dornelles S, Silveira V, Frantz G . Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil. An Bras Dermatol. 2013; 88(5):732-8. PMC: 3798349. DOI: 10.1590/abd1806-4841.20132083. View

15.

Zane C, Facchinetti E, Rossi M, Specchia C, Calzavara-Pinton P . A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp. Br J Dermatol. 2014; 170(5):1143-50. DOI: 10.1111/bjd.12844. View

16.

Serra-Guillen C, Nagore E, Hueso L, Llombart B, Requena C, Sanmartin O . A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate. Br J Dermatol. 2010; 164(2):429-33. DOI: 10.1111/j.1365-2133.2010.10098.x. View

17.

Tran D, Salmon R . Field treatment of facial and scalp actinic keratoses with photodynamic therapy: survey of patient perceptions of treatment satisfaction and outcomes. Australas J Dermatol. 2011; 52(3):195-201. DOI: 10.1111/j.1440-0960.2011.00785.x. View

18.

Chetty P, Choi F, Mitchell T . Primary care review of actinic keratosis and its therapeutic options: a global perspective. Dermatol Ther (Heidelb). 2015; 5(1):19-35. PMC: 4374063. DOI: 10.1007/s13555-015-0070-9. View

19.

de Berker D, McGregor J, Hughes B . Guidelines for the management of actinic keratoses. Br J Dermatol. 2007; 156(2):222-30. DOI: 10.1111/j.1365-2133.2006.07692.x. View

20.

Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P . A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. 2003; 14(2):99-106. DOI: 10.1080/09546630310012118. View